Original Research

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model

Wilson MR, Patel JG, Coleman A, McDade CL, Stanford RH, Earnshaw SR

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:997-1008

Published Date: 24 March 2017